Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,998,848
  • Shares Outstanding, K 328,277
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271,000 K
  • 60-Month Beta 1.70
  • Price/Sales 4.05
  • Price/Cash Flow 5.46
  • Price/Book 1.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
186.50 +6.60%
on 01/31/20
202.21 -1.68%
on 02/12/20
+6.13 (+3.18%)
since 01/17/20
3-Month
183.40 +8.40%
on 11/22/19
202.21 -1.68%
on 02/12/20
+13.59 (+7.34%)
since 11/19/19
52-Week
114.27 +73.98%
on 06/17/19
202.21 -1.68%
on 02/12/20
+60.85 (+44.11%)
since 02/19/19

Most Recent Stories

More News
Beth Fegan of FeganScott Law Firm Named Co-Lead Counsel in Allergan BIOCELL Class Action

Elizabeth A. Fegan, founder and managing partner of FeganScott, was named co-lead counsel in the U.S. district court class-action litigation involving Allergan, the manufacturers of BIOCELL textured and...

AGN : 198.81 (+0.41%)
Global Hospital Infection Therapeutics Market (2020 to 2025) - Key Players Include Merck & Co, Allergan & AstraZeneca Among Others - ResearchAndMarkets.com

The "Hospital Infection Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

AGN : 198.81 (+0.41%)
Global Gastrointestinal Therapeutics Market Witness Highest Growth in near future| Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals International company and Allergan plc

Global Gastrointestinal Therapeutics Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property...

ABT : 89.36 (+0.54%)
AGN : 198.81 (+0.41%)
AZN : 49.31 (+0.41%)
BAYRY : 20.4200 (+0.29%)
GSK : 43.49 (-0.14%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Facial Injectors Market - Global Industry Outlook, Share, Growth Analysis, Trends and Forecast 2020 - 2025

A new research study has been presented by ORBIS RESEARCH after a comprehensive analysis on Global Facial Injectors Market where user can get benefits from the complete market research report with all...

AGN : 198.81 (+0.41%)
MRK : 82.00 (-0.56%)
RVNC : 26.68 (+2.89%)
VRX.TO : 30.80 (-3.33%)
Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020

https://mma.prnewswire.com/media/222796/allergan_plc_logo.jpg

AGN : 198.81 (+0.41%)
Ironwood (IRWD) Surpasses Q4 Earnings and Sales Estimates

Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter as well. Stock up.

IRWD : 11.93 (-1.45%)
AZN : 49.31 (+0.41%)
AGN : 198.81 (+0.41%)
CYCN : 5.84 (+44.55%)
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails

AbbVie (ABBV) and Allergan (AGN) announce Q4 results.

JNJ : 148.94 (-0.13%)
RHHBY : 44.7300 (+1.44%)
MRK : 82.00 (-0.56%)
LLY : 140.83 (-0.13%)
BMY : 65.71 (-0.54%)
AGN : 198.81 (+0.41%)
ABBV : 94.14 (+0.57%)
Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients

https://mma.prnewswire.com/media/222796/allergan_plc_logo.jpg

AGN : 198.81 (+0.41%)
Ophthalmic Drugs Market Size Is Estimated To Expand at a CAGR of 6% By 2025

AGN : 198.81 (+0.41%)
MRK : 82.00 (-0.56%)
PFE : 36.23 (-0.25%)
REGN : 400.81 (+0.79%)
SNPHF : 19.3000 (-0.26%)
SHPG : 179.20 (+4.10%)
TEVA : 13.45 (+9.17%)
VRX.TO : 30.80 (-3.33%)
Teva (TEVA) Q4 Earnings In Line, Stock Up as Sales Stabilize

Teva Pharmaceutical (TEVA) earnings match estimates but sales beat. Shares rise 9%.

TEVA : 13.45 (+9.17%)
RHHBY : 44.7300 (+1.44%)
AGN : 198.81 (+0.41%)
EGRX : 52.87 (-0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 200.14
1st Resistance Point 199.47
Last Price 198.81
1st Support Level 197.84
2nd Support Level 196.88

See More

52-Week High 202.21
Last Price 198.81
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar